PillRx only · Capsule, Extended Release · Oral
Dextroamphetamine Sulfate
Brands: Dexedrine Spansule · Dextroamphetamine Sulfate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.145
Latest avg · Jul 22, 2026
-10%
Since Dec 17, 2025
4
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
22K
Rx · 2026 Q1
1.1M
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Actavis Pharma, Inc. | unknown | 3 | SUPPLYING |
| SpecGx LLC | unknown | 3 | SUPPLYING |
| Amneal Pharmaceuticals of New York LLC | unknown | 3 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 11, 2016RECALLRecall (Class II): Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabe…
Failed Dissolution Specifications — Recalling firm: Actavis Inc — Nationwide
- Feb 10, 2015RECALLRecall (Class II): Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizab…
Failed Dissolution Specifications — Recalling firm: Actavis Elizabeth LLC — Nationwide